Reduction in hippocampal volume is a hallmark of schizophrenia and already present in the
clinical high-risk state. Nevertheless, other subcortical structures, such as the
thalamus, amygdala and pallidum can differentiate schizophrenia patients from controls. We
studied the role of hippocampal and subcortical structures in clinical high-risk
individuals from two cohorts. High-resolution T1-weighted structural MRI brain
scans of a total of 91 clinical high-risk individuals and 64 healthy controls were
collected in two centers. The bilateral volume of the hippocampus, the thalamus, the
caudate, the putamen, the pallidum, the amygdala, and the accumbens were automatically
segmented using FSL-FIRST. A linear mixed-effects model and a prospective meta-analysis
were applied to assess group-related volumetric differences. We report reduced hippocampal
and thalamic volumes in clinical high-risk individuals compared to healthy controls. No
volumetric alterations were detected for the caudate, the putamen, the pallidum, the
amygdala, or the accumbens. Moreover, we found comparable medium effect sizes for
group-related comparison of the thalamus in the two analytical methods. These findings
underline the relevance of specific alterations in the hippocampal and subcortical volumes
in the high-risk state. Further analyses may allow hippocampal and thalamic volumes to be
used as biomarkers to predict psychosis.